Covered already by many folks, but this is a bit embarrassing for Katie Hudson.
- they have changed clinical practice, in this case providing a treatment in a highly unmet medical need space. A therapy for patients that never had one is the definition of changing clinical practice
- we have commercialisation sorted in the US, where it will be expensive for patients but payers have to cover (see first point)
- commercialisation ROW will come in good time
- distribution from our partnership with Acadia is all set.
I'm US-based, work in Biotech and have invested in NEU since 2011. I'm happy I did, but more importantly I'm happy patients have an option when they previously didn't. Working in this space there are very few feel-good stories in our industry. This is one of them.
Katie will figure that out in hindsight I'm sure and we all make mistakes! I thought I had around 2014-18, that's for sure.
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
Covered already by many folks, but this is a bit embarrassing...
-
-
- There are more pages in this discussion • 982 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.01 |
Change
-0.715(3.45%) |
Mkt cap ! $2.570B |
Open | High | Low | Value | Volume |
$20.41 | $20.45 | $19.92 | $2.467M | 122.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 436 | $20.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.01 | 40 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 458 | 20.000 |
8 | 488 | 19.990 |
7 | 4361 | 19.980 |
4 | 324 | 19.970 |
5 | 396 | 19.960 |
Price($) | Vol. | No. |
---|---|---|
20.010 | 40 | 2 |
20.020 | 54 | 2 |
20.030 | 393 | 5 |
20.040 | 234 | 3 |
20.050 | 703 | 6 |
Last trade - 12.47pm 25/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |